A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Clinical trial NCT00057564 · COMPLETED

Trial details

NCT number: NCT00057564
Sponsor: Celgene Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2003-02-01
Primary completion: 2006-04-01
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.